Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Mavacamten in Hypertrophic Cardiomyopathy With Mid-to-Apical Left Ventricular Obstruction
NCT07103655Phase 4Enrolling by invitation
- Sponsor
- Second Affiliated Hospital of Zhejiang University School of Medicine
- Start
- Mar 2026
- Primary completion
- Nov 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of mavacamten in hypertrophic cardiomyopathy (HCM), sponsored by Second Affiliated Hospital of Zhejiang University School of Medicine. Started Mar 2026; status: enrolling by invitation.
02
Drugs
mavacamten
03
Conditions
hypertrophic cardiomyopathy (HCM)
Beyond the preview
Go deeper on NCT07103655.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07103655.